APLM
Price:
$14.305
Market Cap:
$15.78M
Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore,...[Read more]
Industry
Biotechnology
IPO Date
2021-11-26
Stock Exchange
NASDAQ
Ticker
APLM
According to Apollomics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.15M. This represents a change of 364.44% compared to the average of 2.83M of the last 4 quarters.
The mean historical Enterprise Value of Apollomics, Inc. over the last ten years is 578.86M. The current 13.15M Enterprise Value has changed 127.18% with respect to the historical average. Over the past ten years (40 quarters), APLM's Enterprise Value was at its highest in in the December 2020 quarter at 3.73B. The Enterprise Value was at its lowest in in the June 2024 quarter at -1750046.00.
Average
578.86M
Median
867.52M
Minimum
233.12K
Maximum
1.14B
Discovering the peaks and valleys of Apollomics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 10.36%
Maximum Annual Enterprise Value = 1.14B
Minimum Annual Increase = -99.47%
Minimum Annual Enterprise Value = 233.12K
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 24.39M | 10.36% |
| 2024 | 233.12K | -99.47% |
| 2023 | 44.40M | -94.88% |
| 2022 | 867.52M | -23.94% |
| 2021 | 1.14B | 12.02% |
| 2020 | 1.02B | 6.42% |
The current Enterprise Value of Apollomics, Inc. (APLM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
23.01M
5-year avg
415.42M
10-year avg
578.86M
Apollomics, Inc.’s Enterprise Value is greater than SeaStar Medical Holding Corporation (-559927.00), greater than Moleculin Biotech, Inc. (3.96M), greater than Athira Pharma, Inc. (1.07M), greater than Lunai Bioworks Inc. (9.18M), less than Tharimmune, Inc. (66.84M), less than BioLineRx Ltd. (20.85M), less than Adaptimmune Therapeutics plc (31.10M), less than Leap Therapeutics, Inc. (30.18M), greater than GeoVax Labs, Inc. (292.14K), less than Adlai Nortye Ltd. (550.38M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -559927.00 | $8.46M | |
| 3.96M | $14.09M | |
| 1.07M | $26.62M | |
| 9.18M | $10.93M | |
| 66.84M | $139.94M | |
| 20.85M | $14.66M | |
| 31.10M | $75.16M | |
| 30.18M | $31.86M | |
| 292.14K | $1.17M | |
| 550.38M | $547.79M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Apollomics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Apollomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Apollomics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Apollomics, Inc. (APLM)?
What is the 3-year average Enterprise Value for Apollomics, Inc. (APLM)?
What is the 5-year average Enterprise Value for Apollomics, Inc. (APLM)?
How does the current Enterprise Value for Apollomics, Inc. (APLM) compare to its historical average?